Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IDS Receives Prestigious Queens Award

23rd Apr 2012 11:02

RNS Number : 8455B
Immunodiagnostic Systems Hldgs PLC
23 April 2012
 



23 April 2012

 

Immunodiagnostic Systems Holdings plc

 

IDS Receives Prestigious Queens Award for Enterprise in International Trade.

 

Immunodiagnostic Systems Holdings plc ("IDS" or "the Company" or "the Group"), a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, is pleased to receive the Queen's Award for Enterprise in International Trade.

 

The Queen's Awards for Enterprise recognise outstanding achievement by UK businesses in the categories of Innovation, International Trade and Sustainable Development. The awards are presented annually by HM The Queen, and are given for the highest levels of excellence demonstrated by a UK based company. The Enterprise in International Trade Award recognises businesses that have achieved substantial growth in overseas earnings and in commercial success.

 

More than 90% of IDS' products are exported internationally and the Company has continually grown its export revenues over the last six years with net profits increasing from £1,174 million in 2006 to £16,636 million in 2011. IDS is building a global presence with customers throughout the US, Europe and increasingly in Asia including China.

 

IDS is focused on the development of very sensitive, highly specific assays to accurately determine the concentration of biologically important markers in tiny samples of biological fluids such as serum, plasma, saliva and urine. The results of such analyses are of critical importance in the diagnosis of disease, the monitoring of therapy and to biomedical researchers in their quest to more fully understand the underlying biology of disease states. IDS works closely with hospitals, universities and research institutes to bring their innovative ideas and products to market, with the goal of introducing new clinical tests for the more efficient diagnosis of disease.

 

Her Majesty's representative, The Lord-Lieutenant of the County, will present the Award at a special ceremony to be arranged this summer. Details of the event will be available in due course.

 

Ian Cookson, CEO of IDS, said: "This is our third Queen's Award and the receipt of the Enterprise in International Trade Award is a powerful recognition of the dedication of our employees, our growing customer base around the world and of the excellent science that underpins our business. It is a privilege to have been recommended by our Prime Minister, David Cameron and we are delighted to receive this accolade from Her Majesty The Queen."

 

For interview requests, please contact Mo Noonan at [email protected] or Kristina Downey at [email protected].

 

For further information:

 

Immunodiagnostic Systems Holdings plc

Ian Cookson, Chief Executive Officer

Tel : +44 (0)191 5190660

Gerard Murray, Finance Director

Peel Hunt LLP

Tel : +44 (0)207 418 8900

James Steel

Dr Vijay Barathan

FTI Consulting

Tel : +44 (0)207 831 3113

Ben Atwell

Simon Conway

Mo Noonan

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAKMGZDLFLGZZG

Related Shares:

IDH.L
FTSE 100 Latest
Value8,809.74
Change53.53